Adgang til aktieinformation, aktienyheder, selskabsledelser og analytikere.

There may still be upside potential for profitability.

Peace talks change headlines, not procurement, rearmament keeps rolling ahead.

Dagens aktienyheder 30/12-2025 med Pharma Equity Group og Asetek

Peace talks change headlines, not procurement, rearmament keeps rolling ahead.

We have incorporated the company's recently completed refinancing into our estimates and made minimal refinements to our operational forecasts.

Dagens aktienyheder med Skjern Bank og 4 forudsigelser for aktiemarkedet i 2026

The agreement ensures continued cooperation until 2026, but the payment arrangement has shifted from an original cash-based plan to one weighted toward convertible debt.

2026 is the year Saab has to prove it can deliver at scale.

The company will use the proceeds to reduce debt and distribute funds to shareholders.

I dagens Morgenbørs ser vi ind i forholdsvis flade futures med en marginalt positiv stemning i Europa og en marginalt negativ stemning i USA. Herhjemme er der fokus på blandt andet Novo Nordisk og Ørsted.

Dagens aktienyheder med Trifork, ISS, Rovsing og Agillic

Aiforia announced on Monday that it has appointed Antti Ojala as the company's new CFO and a member of the management team.

However, CapMan did not disclose the size of the first closing, so it is not possible to assess the company's success at this point.

Relais' subsidiary Strands Group will acquire 70% of Qpax AB.

Curasight has entered a new clinical phase with both arms of its uPAR-based theranostic platform now in clinical development, following the successful first patient dosing in the Phase I uTREAT® trial in glioblastoma and continued progress in the Phase II uTRACE® prostate cancer study under the partnership with Curium. With diagnostic proof-of-concept already established across multiple indications, the transition of uTREAT® into human trials materially expands the company’s addressable market and shifts investor focus toward the therapeutic upside embedded in the platform.

We believe the share is attractively priced.